Takeda Continues Divestment Spree with US$1.3 B Teijin Pharma Deal to Reduce Debt
By Michelle Liu
Pharma Deals Review: Vol 2021 Issue 3 (Table of Contents)
Published: 9 Mar-2021
DOI: 10.3833/pdr.v2021.i3.2597 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda Pharmaceutical has agreed to divest four type 2 diabetes treatmentsin Japan to Teijin Pharma in exchange for ¥133 B (US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS